Atrayee Basu-Mallick, MD

Phase 3 data show once-daily varagacostat delivers rapid pain relief and strong PFS in desmoid tumors, with manageable dose reductions.

Uncover what still blocks better desmoid care—predicting progression, treating FAP cases, and protecting fertility as new oral therapies emerge.

Experts explain modern desmoid tumor care: earlier systemic therapy, less surgery, and when ablation or radiation fits patients’ goals and risks.

Experts explain desmoid tumor workup, when to watch and when to treat, plus new local options and genetic screening essentials.

Atrayee Basu-Mallick, MD, highlights established and emerging biomarker-directed therapies in colorectal cancer.

Atrayee Basu-Mallick, MD, discusses the importance of clinical research examining the role of circulating tumor DNA in patients with colorectal cancer.

Atrayee Basu-Mallick, MD, discusses factors to consider when selecting a frontline HER2-directed treatment regimen for patients with colorectal cancer.

Atrayee Basu-Mallick, MD, discusses the role of circulating tumor DNA in patients with colorectal cancer.